开云app官网登录入口网页版-官方正版

#ADC药物#

2篇内容 | 1569人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2225615, encodeId=039f222561540, content=<a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a> <a href='/topic/show?id=b6b011e87899' target=_blank style='color:#2F92EE;'>#ESMO 2024#</a> <a href='/topic/show?id=5c1b1190412e' target=_blank style='color:#2F92EE;'>#ESG401#</a> <a href='/topic/show?id=0cdf11904247' target=_blank style='color:#2F92EE;'>#HER2阴性乳腺癌伴脑转移#</a>, objectTitle=ESMO 2024 | 专访马飞教授：TROP2 新型ADC药物！ESG401在HER2阴性乳腺癌伴脑转移患者中展现出突破性疗效, objectType=article, longId=843183, objectId=49df843183f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240913/1726206407330_92910.png, objectUrl=/article/show_article.do?id=49df843183f4, replyNumber=0, likeNumber=11, createdTime=2024-09-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=49df843183f4, moduleTitle=ESMO 2024 | 专访马飞教授：TROP2 新型ADC药物！ESG401在HER2阴性乳腺癌伴脑转移患者中展现出突破性疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=49df843183f4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200408, encodeId=f54e220040802, content=<a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宫颈癌#</a> <a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a>, objectTitle=曹新平教授组稿｜倪镌：ADC药物治疗宫颈癌的进展, objectType=article, longId=823184, objectId=d69982318444, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/busy-reception-in-a-hospital-with-doctors-and-PUPDEB8.jpg, objectUrl=/article/show_article.do?id=d69982318444, replyNumber=0, likeNumber=74, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=d69982318444, moduleTitle=曹新平教授组稿｜倪镌：ADC药物治疗宫颈癌的进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d69982318444)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199208, encodeId=b9352199208df, content=<a href='/topic/show?id=01ba8091ea5' target=_blank style='color:#2F92EE;'>#肌层浸润膀胱癌#</a> <a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a>, objectTitle=Onclive进展悦读：ADC药物在肌层浸润膀胱癌治疗中的研究进展, objectType=article, longId=822183, objectId=061e8221833c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=061e8221833c, replyNumber=0, likeNumber=69, createdTime=2024-04-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=061e8221833c, moduleTitle=Onclive进展悦读：ADC药物在肌层浸润膀胱癌治疗中的研究进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=061e8221833c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181202, encodeId=b62c21812020c, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=78aa999190f' target=_blank style='color:#2F92EE;'>#靶向治疗#</a> <a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a>, objectTitle=年度盘点 | 2023 靶向HER2乳腺癌临床研究年度盘点, objectType=article, longId=807717, objectId=485980e7170d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=485980e7170d, replyNumber=0, likeNumber=88, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=485980e7170d, moduleTitle=年度盘点 | 2023 靶向HER2乳腺癌临床研究年度盘点, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=485980e7170d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2178614, encodeId=808921e861443, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a>, objectTitle=超越化疗？首个肺癌ADC药物Dato-DXd III期数据公布，非鳞癌疗效更优, objectType=article, longId=807803, objectId=858e80e80305, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PPWMQ9L.jpg, objectUrl=/article/show_article.do?id=858e80e80305, replyNumber=0, likeNumber=98, createdTime=2024-01-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=858e80e80305, moduleTitle=超越化疗？首个肺癌ADC药物Dato-DXd III期数据公布，非鳞癌疗效更优, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=858e80e80305)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2166771, encodeId=7e912166e7197, content=<a href='/topic/show?id=dbe010e367ba' target=_blank style='color:#2F92EE;'>#科伦博泰#</a><a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a><a href='/topic/show?id=0b4910e3689e' target=_blank style='color:#2F92EE;'>#SKB264#</a><a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a>新适应症拟纳入优先审评！ , objectTitle=科伦博泰ADC药物SKB264三阴性乳腺癌新适应症拟纳入优先审评！, objectType=article, longId=799408, objectId=5639e99408ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231023/dd28ea0603e2488ca33c5d75ba7b2be3.jpg, objectUrl=/article/show_article.do?id=5639e99408ad, replyNumber=0, likeNumber=99, createdTime=2023-11-05, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=5639e99408ad, moduleTitle=科伦博泰ADC药物SKB264三阴性乳腺癌新适应症拟纳入优先审评！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5639e99408ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241288, encodeId=ce86124128876, content=<a href='/topic/show?id=41e019635b' target=_blank style='color:#2F92EE;'>#ADC药物#</a>获得FDA<a href='/topic/show?id=dad04542ede' target=_blank style='color:#2F92EE;'>#孤儿药#</a>, objectTitle=治疗胃癌！石药ADC药物获得FDA孤儿药资格认定, objectType=article, longId=204115, objectId=d7c4204115f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020124/1607011804933_2119349.jpg, objectUrl=/article/show_article.do?id=d7c4204115f7, replyNumber=0, likeNumber=94, createdTime=2022-08-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c4204115f7, moduleTitle=治疗胃癌！石药ADC药物获得FDA孤儿药资格认定, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d7c4204115f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

ADC药物

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ADC药物# #ESMO 2024# #ESG401# #HER2阴性乳腺癌伴脑转移#

ESMO 2024 | 专访马飞教授：TROP2 新型ADC药物！ESG401在HER2阴性乳腺癌伴脑转移患者中展现出突破性疗效

2024-09-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#宫颈癌# #ADC药物#

曹新平教授组稿｜倪镌：ADC药物治疗宫颈癌的进展

2024-04-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#肌层浸润膀胱癌# #ADC药物#

Onclive进展悦读：ADC药物在肌层浸润膀胱癌治疗中的研究进展

2024-04-18发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#乳腺癌# #靶向治疗# #ADC药物#

年度盘点 | 2023 靶向HER2乳腺癌临床研究年度盘点

2024-01-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #肺癌# #ADC药物#

超越化疗？首个肺癌ADC药物Dato-DXd III期数据公布，非鳞癌疗效更优

2024-01-01发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#科伦博泰##ADC药物##SKB264##三阴性乳腺癌#新适应症拟纳入优先审评！

科伦博泰ADC药物SKB264三阴性乳腺癌新适应症拟纳入优先审评！

2023-11-05发表于威斯康星

循证小兵 (审核中...)

前往app查看评论内容

#ADC药物#获得FDA#孤儿药#

治疗胃癌！石药ADC药物获得FDA孤儿药资格认定

2022-08-27

科室
- - 订阅+
  - 更多科室
工具
服务